Market Research Reports

Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

157pages
Published Date: 2014-01-31
 

Description


Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine system is instrumental in regulating certain body mechanisms such as metabolism, growth and sexual development. Furthermore, endocrine system works in close co-ordination with nervous system to help body cope up with several cellular mechanisms and stress. Responses to stress, absorption of nutrients maintenance of water and electrolyte balance, injury and energy metabolism constitute the major areas of control and integration controlled by the endocrine system. There is a need for regular testing of endocrine hormone levels in the body as any deficiency or overproduction will lead to abnormal functioning of the endocrine gland thereby resulting in development of certain endocrine disorders. For instance, deficiency or overproduction of thyroid hormone results in hypothyroidism or hyperthyroidism respectively. 

Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests. 

The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting the deficiency (hyposecretion) or excess (hypersecretion) secretions of these hormones. The diagnostic technologies segment further describes the technological platforms used in the analysis of the specimen test sample (blood, urine, etc) and is further categorized into five major technologies, tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor and clinical chemistry technologies. The end user segment elucidates the endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician’s offices. 

A detailed market analysis and forecast for each of these segments have been provided in this study, in terms of market revenue (USD million) for the period 2011 to 2019. The report also provides the compounded annual growth rate (CAGR %) for each of these segments for the forecast period from 2013 to 2019, considering 2011 and 2012 as base years.

On the basis of geography, the market is classified into North America, Europe, Asia-Pacific, Africa, Latin America and Rest of the World (RoW). The current and future market size in terms of revenue (USD million) and volume (number of units) for each of these regions along with CAGR have also been provided in the report, considering from 2013 to 2019 as a forecast period and, 2011 and 2012 as base years. 

The market overview section of the report elucidates the major market dynamics such as drivers, restraints and opportunities that influence the current as well as future market trends of the industry. A PESTLE analysis has also been considered while estimating the market for individual geographies in order to provide current as well as future status. 

Several other analytical perspectives such as Porter’s Five Forces Analysis, market share analysis and market attractiveness have been described in the report in order to give a thorough analysis of the market. Also, a list of recommendations for existing as well as new entrants has also been discussed in the study which would help in decision making. The report concludes with the company profiles section including key information about the key players in the market such as financial overview, business strategies, product portfolio and recent developments. Abbott Laboratories, AB SCIEX LLC, DiaSorin S.p.A, F.Hoffmann-La Roche, Ltd., Sysmex Corporation, Thermo Fisher Scientific and Agilent Technologies are some of the key players operating in this market.

The global endocrine testing market is segmented into the following categories:
  • Hernia Endocrine Testing Market, by Tests
    • Estradiol (E2) Test
    • Follicle Stimulating Hormone (FSH) Test
    • Human Chorionic Gonadotropin (hCG) Test
    • Luteinizing Hormone (LH) Test
    • Dehydroepiandrosterone sulfate (DHEAS) Test
    • Progesterone Test
    • Testosterone Test
    • Thyroid Stimulating Hormone (TSH) Test
    • Prolactin Test
    • Cortisol Test
    • Insulin Test
    • Others (Gastrin, Thymosin, Secretin, etc.)
  • Endocrine Testing Market, by Diagnostic Technologies
    • Tandem Mass spectrometry
    • Immunoassay (Enzyme immunoassays, Radioimmunoassays  (RIA)) Technologies
    • Monoclonal and Polyclonal Antibody Technologies
    • Sensor (Electrochemical, Biosensors, etc.) Technologies
    • Clinical Chemistry Technologies
    • Others (Liquid Chromatography + Mass Spectrometry (LC-MS), High performance Liquid Chromatography (HPLC), etc.)
  • Endocrine Testing Market, by Geography
    • Hospitals
    • Commercial Laboratories
    • Ambulatory Care Centers
    • Home Based Tests
    • Physician Offices
  • Endocrine Testing Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Table of Contents



Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
               1.3.1.1 Secondary Research
               1.3.1.2 Primary Research
               1.3.1.3 Models
               1.3.1.4 Assumptions
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Endocrine Testing Market (2012 & 2019)
2.2 Global Endocrine Testing Market, by Test, 2012 (USD Million)
2.3 Global Endocrine Testing Market, by Diagnostic Technologies, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Overview
      3.1.1 Introduction to Elements of Endocrine System
      3.1.2 Market Potential of Endocrine Testing Market
      3.1.3 Future Scenario of Endocrine Testing Market
3.2 Market Dynamics
      3.2.1 Market Drivers
              3.2.1.1 Increasing Incidence of diabetic and obese population worldwide
              3.2.1.2 Consistent rise in geriatric population Worldwide
              3.2.1.3 Technological advancements
      3.2.2 Market Restraints
              3.2.2.1 High cost of technology
              3.2.2.2 Lack of healthcare awareness in emerging economies
     3.2.3 Market Opportunity
              3.2.3.1 Investment opportunity
3.3 Porter’s Five Force Analysis for the Global Endocrine Testing Market
     3.3.1 Bargaining power of suppliers
     3.3.2 Bargaining power of buyers
     3.3.3 Threat of substitutes
     3.3.4 Threat of new entrants
     3.3.5 Competitive rivalry
3.1 Market Attractiveness Analysis: Global Endocrine Technologies Market, by Geography

Chapter 4 Endocrine Testing Market, by Test
4.1 Overview
     4.1.1 Global Endocrine Testing Market, by Test, 2011 – 2019 (USD Million)
4.2 Estradiol (E2) Test
     4.2.1 Global Estradiol (E2) Test Market, 2011 – 2019 (USD Million)
4.3 Follicle Stimulating Hormone (FSH) Test
     4.3.1 Global Follicle Stimulating Hormone (FSH) Test Market, 2011 – 2019 (USD Million)
4.4 Human Chorionic Gonadotropin (hCG) Test
     4.4.1 Global Human Chorionic Gonadotropin (hCG) Test Market, 2011 – 2019 (USD Million)
4.5 Luteinizing Hormone (LH) Test
     4.5.1 Global Luteinizing Hormone (LH) Test Market, 2011 – 2019 (USD Million)
4.6 Dehydroepiandrosterone Sulfate (DHEAS) Test
     4.6.1 Global Dehydroepiandrosterone Sulfate (DHEAS) Test Market, 2011 – 2019 (USD Million)
4.7 Progesterone Test
     4.7.1 Global Progesterone Test Market, 2011 – 2019 (USD Million)
4.8 Testosterone Test
     4.8.1 Global Testosterone Test Market, 2011 – 2019 (USD Million)
4.9 Thyroid Stimulating Hormone (TSH) Test
     4.9.1 Global Thyroid Stimulating Hormone (TSH) Test Market, 2011 – 2019 (USD Million)
4.10 Prolactin Test
     4.10.1 Global Prolactin Test Market, 2011 – 2019 (USD Million)
4.11 Cortisol Test
     4.11.1 Global Cortisol Test Market, 2011 – 2019 (USD Million)
4.12 Insulin Test
     4.12.1 Global Insulin Test Market, 2011 – 2019 (USD Million)
4.13 Others
     4.13.1 Global Others Market, 2011 – 2019 (USD Million)

Chapter 5 Endocrine Testing Market, by Diagnostic Technologies
5.1 Overview
     5.1.1 Global Endocrine Testing Market, by Diagnostic Technologies 2011 – 2019 (USD Million)
5.2 Tandem Mass Spectrometry
     5.2.1 Global Tandem Mass Spectrometry Market, 2011 – 2019 (USD Million)
5.3 Immunoassay (Enzyme Linked Assays(EIA), Radio Immunoassay (RIA))Technologies
     5.3.1 Global Immunoassay Technologies Market, 2011 – 2019 (USD Million)
5.4 Monoclonal and Polyclonal Antibody Technologies
     5.4.1 Global Monoclonal and Polyclonal Antibody Technologies Market, 2011 – 2019 (USD Million)
5.5 Sensor Technologies
      5.5.1 Global Sensor Technologies Market, 2011 – 2019 (USD Million)
5.6 Clinical Chemistry Technologies
      5.6.1 Global Clinical Chemistry Technologies Market, 2011 – 2019 (USD Million)
5.7 Others ((Liquid Chromatography + Tandem Mass Spectrometry (LC-MS/MS), High performance Liquid Chromatography (HPLC), etc.)
      5.7.1 Global Others Market, 2011 – 2019 (USD Million)

Chapter 6 Endocrine Testing Market, by End Users
6.1 Overview
      6.1.1 Global Endocrine Testing Market, by End Users 2011 – 2019 (USD Million)
6.2 Hospitals
      6.2.1 Global Hospitals Market, 2011 – 2019 (USD Million)
6.3 Commercial Laboratories
      6.3.1 Global Commercial Laboratories Market, 2011 – 2019 (USD Million)
6.4 Ambulatory Care Centers
      6.4.1 Global Ambulatory Care Centers Market, 2011 – 2019 (USD Million)
6.5 Home Based Tests
      6.5.1 Global Home Based Tests Market, 2011 – 2019 (USD Million)
6.6 Physician Offices
      6.6.1 Global Physician Offices Market, 2011 – 2019 (USD Million)

Chapter 7 Endocrine Testing Market, by Geography
7.1 Overview
      7.1.1 Global Endocrine Testing Market, by Geography 2011 – 2019 (USD Million)
7.2 North America
      7.2.1 North America Endocrine Testing Market, 2011 – 2019 (USD Million)
7.3 Europe
      7.3.1 Europe Endocrine Testing Market, 2011 – 2019 (USD Million)
7.4 Asia-Pacific
      7.4.1 Asia-Pacific Endocrine Testing Market, 2011 – 2019 (USD Million)
7.5 Rest of the World (RoW)
      7.5.1 RoW Endocrine Testing Market, 2011 – 2019 (USD Million)

Chapter 8 Competitive Landscape
8.1 Market Share by Key Players: Global Endocrine Testing Market, 2012 (%)
      8.1.1 Global Endocrine Testing Market Share Analysis, by Key Players, 2012 (%)

Chapter 9 Recommendations
9.1 Market strategies for success
9.2 Barriers to be considered

Chapter 10 Company Profiles
10.1 Abbott Laboratories
      10.1.1 Company Overview
      10.1.2 Financial Overview
      10.1.3 Product Portfolio
      10.1.4 Business Strategies
      10.1.5 Recent Developments
10.2 AB SCIEX LLC
      10.2.1 Company Overview
      10.2.2 Financial Overview
      10.2.3 Product Portfolio
      10.2.4 Business Strategies
      10.2.5 Recent Developments
10.3 Agilent Technologies
      10.3.1 Company Overview
      10.3.2 Financial Overview
      10.3.3 Product Portfolio
      10.3.4 Business Strategies
      10.3.5 Recent Developments
10.4 Biomedical Diagnostics
      10.4.1 Company Overview
      10.4.2 Financial Overview
      10.4.3 Product Portfolio
      10.4.4 Business Strategies
      10.4.5 Recent Developments
10.5 bioMerieux
      10.5.1 Company Overview
      10.5.2 Financial Overview
      10.5.3 Product Portfolio
      10.5.4 Business Strategies
      10.5.5 Recent Developments
10.6 Bio-Rad Laboratories, Inc.
      10.6.1 Company Overview
      10.6.2 Financial Overview
      10.6.3 Product Portfolio
      10.6.4 Business Strategies
      10.6.5 Recent Developments
10.7 DiaSorin S.p.A
      10.7.1 Company Overview
      10.7.2 Financial Overview
      10.7.3 Product Portfolio
      10.7.4 Business Strategies
      10.7.5 Recent Developments
10.8 F. Hoffmann-La Roche Ltd.
      10.8.1 Company Overview
      10.8.2 Financial Overview
      10.8.3 Product Portfolio
      10.8.4 Business Strategies
      10.8.5 Recent Developments
10.9 Laboratory Corporation of America Holdings (LabCorp)
       10.9.1 Company Overview
       10.9.2 Financial Overview
       10.9.3 Product Portfolio
       10.9.4 Business Strategies
       10.9.5 Recent Developments
10.10 Ortho Clinical Diagnostics
         10.10.1 Company Overview
         10.10.2 Financial Overview
         10.10.3 Product Portfolio
         10.10.4 Business Strategies
         10.10.5 Recent Developments
10.11 Quest Diagnostics
         10.11.1 Company Overview
         10.11.2 Financial Overview
         10.11.3 Product Portfolio
         10.11.4 Business Strategies
         10.11.5 Recent Developments
10.12 Siemens Healthcare
         10.12.1 Company Overview
         10.12.2 Financial Overview
         10.12.3 Product Portfolio
         10.12.4 Business Strategies
         10.12.5 Recent Developments
10.13 Sysmex Corporation
         10.13.1 Company Overview
         10.13.2 Financial Overview
         10.13.3 Product Portfolio
         10.13.4 Business Strategies
         10.13.5 Recent Developments
10.14 Thermo Fisher Scientific
         10.14.1 Company Overview
         10.14.2 Financial Overview
         10.14.3 Product Portfolio
         10.14.4 Business Strategies
         10.14.5 Recent Developments

List of Figures

FIG. 1 Endocrine Testing: Market Segmentation
FIG. 2 Global Endocrine Testing Market, by Test, 2012 (USD Million)
FIG. 3 Global Endocrine Testing Market, by Diagnostic Technology, 2012 (USD Million)
FIG. 4 Introduction to Endocrine Glands/organs
FIG. 5 Global Rate of Aging Population
FIG. 6 Porter’s Five Forces Analysis: Global Endocrine Testing Market
FIG. 7 Market Attractiveness Analysis: Global Endocrine Testing  Market, by Geography
FIG. 8 Global Estradiol (E2) Test Market, 2011 – 2019 (USD Million)
FIG. 9 Global Follicle Stimulating Hormone (FSH) Test Market, 2011 - 2019 (USD Million)
FIG. 10 Global Human Chorionic Gonadotropin (hCG) Test Market, 2011 - 2019 (USD Million)
FIG. 11 Global Luteinizing Hormone (LH) Test Market, 2011 - 2019 (USD Million)
FIG. 12 Global Dehydroepiandrosterone Sulfate (DHEAS) Test Market, 2011 - 2019 (USD Million)
FIG. 13 Global Progesterone Test Market, 2011 - 2019 (USD Million)
FIG. 14 Global Testosterone Test Market, 2011 - 2019 (USD Million)
FIG. 15 Global Thyroid Stimulating Hormone (TSH) Test Market, 2011 - 2019 (USD Million)
FIG. 16 Global Prolactin Test Market, 2011 - 2019 (USD Million)
FIG. 17 Global Cortisol Test Market, 2011 - 2019 (USD Million)
FIG. 18 Global Insulin Test Market, 2011 - 2019 (USD Million)
FIG. 19 Global Others Market, 2011 - 2019 (USD Million)
FIG. 20 Global Tandem Mass Spectrometry Market, 2011 - 2019 (USD Million)
FIG. 21 Global Immunoassay Technologies Market, 2011 - 2019 (USD Million)
FIG. 22 Global Monoclonal and Polyclonal Antibody Technologies Market, 2011 - 2019 (USD Million)
FIG. 23 Global Sensor Technologies Market, 2011 - 2019 (USD Million)
FIG. 24 Global Clinical Chemistry Technologies Market, 2011 - 2019 (USD Million)
FIG. 25 Global Others Market, 2011 - 2019 (USD Million)
FIG. 26 Global Hospitals Market, 2011 - 2019 (USD Million)
FIG. 27 Global Commercial Laboratories Market, 2011 - 2019 (USD Million)
FIG. 28 Global Ambulatory Care Centers Market, 2011 - 2019 (USD Million)
FIG. 29 Global Home Based Tests Market, 2011 - 2019 (USD Million)
FIG. 30 Global Physician Offices Market, 2011 - 2019 (USD Million)
FIG. 31 North America Endocrine Testing Market, 2011 - 2019 (USD Million)
FIG. 32 Europe Endocrine Testing Market, 2011 - 2019 (USD Million)
FIG. 33 Asia-Pacific Endocrine Testing Market, 2011 - 2019 (USD Million)
FIG. 34 RoW Endocrine Testing Market, 2011 - 2019 (USD Million)
FIG. 35 Endocrine Testing: Market Share, by Key Players, 2012 (%)
FIG. 36 Abbott Laboratories, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 37 Agilent Technologies, Annual Revenue: 2010 – 2012 (USD million,)
FIG. 38 bioMerieux, Annual Sales Revenue: 2010 – 2012 (USD Million) Conversion Rate 1Euro = 1.34 USD
FIG. 39 Bio-Rad, Annual Sales Revenue : 2010 – 2012 (USD Million)
FIG. 40 DiaSorin, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 41 F. Hoffmann-La Roche Ltd.: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 42 LabCorp: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 43 Ortho Clinical Diagnostics, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 44 Quest Diagnostics, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 45 Siemens Healthcare, Annual Revenue: 2010 – 2012 (USD Billion)
FIG. 46 Sysmex Corporation, Annual Sales: 2011 – 2013 (USD million)
FIG. 47 Thermo Fisher Scientific, Annual Revenue: 2010 – 2012 (USD million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Endocrine Testing Market (2012 & 2019)
TABLE 3 Impact Analysis of Market Drivers
TABLE 4 Impact Analysis of Market Restraints
TABLE 5 Global Endocrine Testing Market, by Test, 2011 – 2019 (USD Million)
TABLE 6 Estradiol Test Result Range
TABLE 7 The Reasons For Performing FSH Test
TABLE 8 Progesterone Test Result Range
TABLE 9 Global Endocrine Testing Market, by Diagnostic Technologies 2011 – 2019 (USD Million)
TABLE 10 Global Endocrine Testing Market, by Ed Users 2011 – 2019 (USD Million)
TABLE 11 Global Endocrine Testing Market, by Geography 2011 – 2019 (USD Million)

Enquiry Before Buying


Free Market Analysis


Endocrine glands and hormones are major elements of the endocrine system that are crucial for regulation of several body mechanisms such as growth, development and homeostasis. Responses to stress, injury, absorption of nutrients maintenance of water and electrolyte balance and energy metabolism constitutes major areas of control and integration offered by the endocrine system. There are endocrine glands (pituitary, pineal, thyroid and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream. These glands have rich blood supply which facilitate movement of hormones to reach their target organs and enablevarious alterationsin metabolism of target organs by increasing or decreasing their activity. 

Endocrine tests are crucial for monitoring normal functioning of endocrine system since any deviation (hypersecretion or hyposecretion) from the normal levels of hormones results in development of various endocrine disorders such as diabetes, thyroid, cancer and infertility. These tests enable both qualitative and quantitative determination of the hormone levels and can be performed either in hospitals, commercial laboratories (thyroid hormone tests, progesterone tests) or even at home (pregnancy test kit, blood sugar test strips). Endocrine testing market is witnessing increasing growth and adoption majorly due to constant rise in several disorders such as diabetes, thyroid and reproductive system disorders.These disorders indicate the abnormal level of endocrine hormones in the body thereby creating a need and demand for effective endocrine testing kits. In addition, continuous evolution of diagnostic platforms followed by increasing healthcare awareness would further augment the growth and development of endocrine testing platforms. The global market for endocrine testing market was valued at USD 1,537.5 million in 2012 growing at a CAGR of 4.3% from 2013 to 2019.

global-endocrine-testing-market-by-tests-2012

Endocrine testing market can be analyzed by the type of tests involved, diagnostic platforms and end users. The various hormone tests refer to estradiol, Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing Hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Testosterone, Thyroid Stimulating Hormone (TSH), Prolactin, Cortisol, Insulin tests and others. Thyroid stimulating hormone test market was estimated to be the largest market segment in 2012 growing at a CAGR of 5.4% during the forecast period. This is attributed to high prevalence of thyroid disorders among geriatric population and also is more common in females than males with a female to male ratio of 10:1. Also, as per the research findings published in Elsevier, Inc., among the population aged above 65, 1.7% have hypothyroidism and 13.7% of aging population have subclinical hypothyroidism. Insulin test is expected to be the fastest growing segment during the forecast period from 2013 to 2019. The major reason being constant rise in diabetic and obese population across the globe. 

According to World Health Organization (WHO), diabetes is predicted to become the seventh leading cause of death by 2030 worldwide and around 80% of diabetes deaths occur in low and middle income nations due to poor management of the disease. However, efforts have been undertaken to increase the awareness about diabetes, International Diabetes Federation (IDF) and WHO declared November 14 as World Diabetes Day and the theme for 2013 was “Prevent diabetes and protect our future”. Such initiatives will ensure awareness about proper management of diabetes thereby facilitating growth and development of endocrine testing market. 

Novel and innovative diagnostic technologies enhance the growth and uptake of several endocrine tests. Immunoassays, clinical chemistry, sensor, tandem mass spectrometry and antibody technologies are the most popular technological platforms employed for performing several endocrine tests. Factors such as consistent innovation in diagnostic technologies followed by enhanced capabilities (high precision, sensitivity and accuracy) and low susceptibility for errors encourages further growth and development of efficient technology platforms. Use of tandem mass spectrometry will witness commendable growth as this platform enables an accurate measurement of even small quantities of hormone levels from the biological samples. Tandem mass spectrometry segment is estimated to be the fastest growing diagnostic technology segment during the forecast period. Moreover, immunoassays and sensor technologies market recorded second and third highest growth rate, respectively, during the forecast period. Several end users represent hospitals, laboratories, ambulatory care centers, home based tests and others that facilitate endocrine testing. Increasing preference of the customers towards instant test results followed by low cost supports the growth and adoption of ambulatory care centers and home based test kits over the others (hospitals, laboratories). 

Geographically, Europe accounts for the largest percentage share of the global endocrine testing market accounting for more than 28% of the total market in 2012. This is justified by the presence of technologically updated infrastructure and well trained healthcare professionals in this region compared to the other regions. In addition, consistent rise in awareness levels in patient population has further augmented growth and development of endocrine testing kits in this region. Also, as per the data enumerated by Organization for Economic Co-operation and Development (OECD) Library, in the year 2012, more than 52% of adult population is overweight or obese and is prevalent in around 18 out of 27 European Union member nations. These statistics further accentuate the growth and uptake of several endocrine tests in this region. Asia-Pacific region is anticipated to record a high growth rate owing to increased participation of the respective governments in improving the overall healthcare sector and tapping huge untapped potential in these regions. In addition, rise in disposable income and increased preference of the population to avail technologically advanced medical solutions will further support the growth of endocrine testing market. North America is also expected to exhibit considerable growth rate majorly due to increased acceptance towards novel approaches and consistent improvements in healthcare facilities in this region.


global-endocrine-testing-market-by-diagnostic-technologies-2012

The overall endocrine testing market is highly fragmented with the presence of both established and emerging companies in this field which includes Agilent Technologies, Abbott Laboratories, F.Hoffmann-La Roche and DiaSorin S.p.A, bioMerieux, Thermo Fisher Scientific and others. The factors which contribute to the growth of the overall endocrine testing market are continuous product modifications followed by technological advances and increasing incidence of diabetic and obese population across the world. However, high costs involved in the development of technologies along with uncertain reimbursement policies may limit growth prospects for the development of effective endocrine tests and methodologies. 

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research